Mohamed Emam Sobeih, Co-Chair of Membership Working Group at European School of Oncology College, shared on LinkedIn:
“Proud to share that 6 abstracts have been accepted for presentation at ESMO Congress 2026.
This achievement reflects the power of collaboration, curiosity, and our shared commitment to improving cancer care through meaningful clinical research.
I would like to express my sincere gratitude to my outstanding Professors and collaborators for their invaluable contribution.
- Prof. Ola Khorshid
- Prof. Ayman Abdelsamie Gaber
- Dr Nouran Muhammed
- Dr Hadeer Adel
- Dr Sherin Mahoud
- Dr Hagar Karam
- Dr Marium Emad
- Dr Radwa Hussein
Thank you for your dedication, scientific insight, and teamwork throughout these projects. It has been a privilege working alongside such an inspiring group.
Looking forward to presenting our work and contributing to the global oncology community at ESMO 2026.
- 2152 – Real-World Outcomes of Malignant Pleural Mesothelioma in Egypt: A Five-Year Single-Institution Experience.
- 4189 – Adoption of Generative AI in Oncology Across MENA: An Infodemiology and Bibliometric Study.
- 2147 – Cost-Effectiveness of Khorana Score-Guided Thromboprophylaxis in Ambulatory Thoracic Malignancy Patients.
- 2148 – Duration of First-Line Chemotherapy as a Critical Independent Prognostic Factor in Malignant Pleural Mesothelioma: Insights from a Resource-Challenged Setting.
- 2149 – Predominance of Epithelioid Histology Coupled with Short Overall Survival in Egyptian Malignant Pleural Mesothelioma: A Focus on the Role of Treatment Intensity.
- 2154 – Treatment Intensity and Host Immunity Define Survival in Diffuse Pleural Mesothelioma: A Real-World Risk Model from a High-Burden Region.”
Other articles about ESMO 2026 on OncoDaily.